» Articles » PMID: 37607536

A Pan-cancer Single-cell Panorama of Human Natural Killer Cells

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 2023 Aug 22
PMID 37607536
Authors
Affiliations
Soon will be listed here.
Abstract

Natural killer (NK) cells play indispensable roles in innate immune responses against tumor progression. To depict their phenotypic and functional diversities in the tumor microenvironment, we perform integrative single-cell RNA sequencing analyses on NK cells from 716 patients with cancer, covering 24 cancer types. We observed heterogeneity in NK cell composition in a tumor-type-specific manner. Notably, we have identified a group of tumor-associated NK cells that are enriched in tumors, show impaired anti-tumor functions, and are associated with unfavorable prognosis and resistance to immunotherapy. Specific myeloid cell subpopulations, in particular LAMP3 dendritic cells, appear to mediate the regulation of NK cell anti-tumor immunity. Our study provides insights into NK-cell-based cancer immunity and highlights potential clinical utilities of NK cell subsets as therapeutic targets.

Citing Articles

NLRP4 unlocks an NK/macrophages-centered ecosystem to suppress non-small cell lung cancer.

Meng Z, Li J, Wang H, Cao Z, Lu W, Niu X Biomark Res. 2025; 13(1):44.

PMID: 40087771 DOI: 10.1186/s40364-025-00756-4.


Single-cell RNA sequencing revealed changes in the tumor microenvironment induced by radiotherapy for cervical cancer and the molecular mechanism of mast cells in immunosuppression.

Xue L, Gao L, Zhou S, Yan C, Zhang X, Lin W Funct Integr Genomics. 2025; 25(1):63.

PMID: 40082276 DOI: 10.1007/s10142-025-01564-7.


Agent-based modeling of cellular dynamics in adoptive cell therapy.

Wang Y, Casarin S, Daher M, Mohanty V, Dede M, Shanley M bioRxiv. 2025; .

PMID: 40027823 PMC: 11870559. DOI: 10.1101/2025.02.17.638701.


High-dimensional deconstruction of HNSC reveals clinically distinct cellular states and ecosystems that are associated with prognosis and therapy response.

Xiao L, Shen Z, Pan Z, Qiu Y, Huang D, Liu Y J Transl Med. 2025; 23(1):254.

PMID: 40025504 PMC: 11872339. DOI: 10.1186/s12967-025-06299-4.


Comprehensive analysis of lipid metabolic signatures identified CEBPD promotes breast cancer cell proliferation.

Zhao Y, He H, Huang L, Yu L Sci Rep. 2025; 15(1):6570.

PMID: 39994306 PMC: 11850814. DOI: 10.1038/s41598-025-90869-5.